US 12,346,508 B2
Systems, devices and methods for managing glucose levels
Erwin S. Budiman, Fremont, CA (US)
Assigned to ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed by ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed on Jun. 9, 2021, as Appl. No. 17/343,236.
Application 17/343,236 is a continuation of application No. 16/128,100, filed on Sep. 11, 2018, granted, now 11,061,491.
Application 16/128,100 is a continuation of application No. 15/093,010, filed on Apr. 7, 2016, granted, now 10,078,380, issued on Sep. 18, 2018.
Application 15/093,010 is a continuation of application No. 13/044,521, filed on Mar. 9, 2011, granted, now 9,326,709, issued on May 3, 2016.
Claims priority of provisional application 61/312,644, filed on Mar. 10, 2010.
Prior Publication US 2022/0057868 A1, Feb. 24, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. G06F 3/0362 (2013.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61M 5/172 (2006.01); G06F 3/01 (2006.01); H01H 3/00 (2006.01)
CPC G06F 3/0362 (2013.01) [A61B 5/14532 (2013.01); A61M 5/1723 (2013.01); G06F 3/016 (2013.01); A61B 5/7455 (2013.01); A61B 5/746 (2013.01); A61B 2560/0276 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/505 (2013.01); A61M 2205/582 (2013.01); A61M 2230/201 (2013.01); H01H 2003/008 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A glucose monitoring system, comprising:
(1) a sensor control unit, comprising:
an in vivo glucose sensor, at least a portion of which is configured to be positioned under a patient's skin, and
an adhesive patch disposed on a bottom surface of the sensor control unit, the adhesive patch configured to adhere the sensor control unit to the patient's skin;
(2) a glucose monitoring unit, comprising:
a compact housing configured to be worn by the patient,
one or more processors disposed within the compact housing,
a transceiver configured for wireless communication with the sensor control unit,
a touch screen operatively coupled with the one or more processors, the touch screen configured to display a user interface to receive, via tactile contact by the patient, an inputted value associated with one or more parameters of the glucose monitoring unit, and
a feedback mechanism, wherein the one or more processors control the feedback mechanism to provide a haptic feedback response to the patient as the inputted value moves toward or away from at least one predefined value associated with the one or more parameters.